XPONDRE Trademark

Trademark Overview

On Thursday, December 20, 2018, a trademark application was filed for XPONDRE with the United States Patent and Trademark Office. The USPTO has given the XPONDRE trademark a serial number of 88237393. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by CytomX Therapeutics, Inc.. The XPONDRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
xpondre

General Information

Serial Number88237393
Word MarkXPONDRE
Filing DateThursday, December 20, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytomX Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCytomX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 24, 2021SOU EXTENSION 5 GRANTED
Monday, November 22, 2021SOU EXTENSION 5 FILED
Monday, November 22, 2021TEAS EXTENSION RECEIVED
Saturday, June 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 3, 2021SOU EXTENSION 4 GRANTED
Thursday, June 3, 2021SOU EXTENSION 4 FILED
Thursday, June 3, 2021TEAS EXTENSION RECEIVED
Friday, January 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 31, 2020SOU EXTENSION 3 GRANTED
Friday, December 11, 2020SOU EXTENSION 3 FILED
Thursday, December 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 11, 2020TEAS EXTENSION RECEIVED
Saturday, June 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2020SOU EXTENSION 2 GRANTED
Thursday, June 18, 2020SOU EXTENSION 2 FILED
Thursday, June 18, 2020TEAS EXTENSION RECEIVED
Wednesday, December 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2019SOU EXTENSION 1 GRANTED
Monday, December 16, 2019SOU EXTENSION 1 FILED
Monday, December 16, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 15, 2019ASSIGNED TO EXAMINER
Sunday, January 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 24, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

xpondre cancer treatment preparations pharmaceutical